CRB Webinars Session 3: Thursday, July 15, 2021 • 5:00 P.M. EDT
Mastering the Paradigm Shift: Anonymous To Disclosed Donors
By Heidi Hayes
Thursday, July 15, 2021, 5:00 P.M. EDT • 1.0 Contact Hour PEER-approved
This talk will review the impact of DNA banks and social media on gamete donation, review the current state of disclosure amongst fertility practices and help the fertility practice navigate change to an open donation clinic.
- Understand the magnitude of the impact of DNA banks and social media on donor gametes
- Discuss the multiple definitions related to anonymous and known donor
- Review the current state of disclosure - ASRM 2019 Mental Health SIG survey
- Highlight donor centric issues versus recipient centric
- Explore navigating change within the fertility practice construct
About our speaker:
Executive Vice President and Co-Founder
Donor Egg Bank USA, a Generate Life Sciences Company
Heidi Hayes has more than 25 years of healthcare experience, having worked as an Executive in the fields of pain management, physical therapy, dialysis and reproductive endocrinology. In 2010, Heidi launched Donor Egg Bank USA, the first donor egg bank to ship vitrified eggs from program to program successfully in the United States and Canada. Heidi understands first hand the challenges associated with infertility and the psychological roller coaster of treatment. She and her husband are the parents of three children and have built their family through adoption and donor egg treatment.
Legal Developments Impacting ART
By Jeffrey J. Sherrin, Esq.
Existing and new frontiers of liability relating to donor anonymity, including
- Changes in expectations of and requirements for anonymity or non-disclosure…the Impact of DNA analysis (23 and Me et al.)
- Evolving lawsuits and legal claims against clinics, banks and donors
- Outer reaches of potential legal claims and liabilities
About our speaker:
Jeffrey J. Sherrin, Esq.
Senior Partner, O’Connell and Aronowitz, P.C.
AAB/CRB Legal Counsel
Albany, New York
Jeffrey Sherrin is a senior partner and former president of O’Connell & Aronowitz, P.C., an Albany-based law firm with a national health care practice. Jeffrey has represented and counseled a broad spectrum of health care providers and trade associations, with a particular focus on clinical laboratories, for approximately 40 years. He has been general counsel to the American Association of Bioanalysts, and AAB’s affiliated organizations and interest groups, since 1984. He is also an accomplished litigator in health care, commercial and employment cases, and has successfully represented AAB and individual labs in lawsuits against the Federal Government, the New York State Department of Health, and commercial payors. Jeffrey is regularly tapped to speak at national conferences and forums on a wide range of issues affecting clinical laboratories.
Dara S. Berger, Ph.D., HCLD/TS(ABB)
University of Pennsylvania’s Clinical IVF Program, Penn Fertility Care